[Federal Register: December 6, 2004 (Volume 69, Number 233)]
[Notices]
[Page 70471]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06de04-60]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 19, 2004, Organichem,
Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................ I
Amphetamine (1100).......................... II
Methylphenidate (1724)...................... II
Pentobarbital (2270)........................ II
Meperidine (9230)........................... II
Dextropoxyphene (9273)...................... II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
internally and for distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: DEA Federal Register Representative,
Office of Liaison and Policy (ODLR) and must be filed no later than
February 4, 2005.
Dated: November 22, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-26737 Filed 12-3-04; 8:45 am]
BILLING CODE 4410-09-P